HIv Flashcards

1
Q

MC strain

A

HIv1 M group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MC transmitting strain

A

R5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MC strain in brain

A

R5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antibodies order of appearance

A

Gp41
P24
Gp120

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 targets in the brain

A

Pero valvular astrocytes
Peri valvular macrophage
Microglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

5 reasons for false positive EIA

A
HAPIT
Hepatic disease
Acute viral illness 
Pregnancy
Influenza vaccine
Transfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Stages

1-3

A

Stage 1 CD4 >500 26%
CD4 200-499 14-25%
CD4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Gag gene

A

Core + p24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pol gene

A

Protease

Rev transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Env gene

A

Envelope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

First cytokines

A

IFN alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HIV lipodystrophy

A

IL18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

3 tests of western blot indeterminate

A

P24 capture
HIV rbs
HIV DNA PCR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When to use cd4 %

A

IFN alpha treatment

Hypersplenism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Infections CD 4

A

PCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Infections CD4

A

Mac
Toxoplasma
CMV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

3 stages of HIV

A

Acute infection 3-6 mos
A symptomatic 10 yrs
AIDS if

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CD4 level to start ART

A

CD4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Most potent and safest ARTs

A

Integrate inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Treatment monitoring

A

HIV RNA at 6 MOA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

4 NNRT

A
NEED
Nevirapine
efavirenz 
Etta
Delav
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Major co receptors for HIV1

A

CCR5

CXCR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HIV type that dominates the global pandemic

It is more transmissible than the others

A

HIV 1 M group subtype C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Predominant HIV type in Asia

A

HIV1 isolates of the CRF01_AE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Predominant HIV in US Canada Europe

A

Subtype B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Natural reservoir of HIV M and N subgroups

A

Pan troglodytes troglodytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Natural reservoir of HIV O and P groups

A

Cameroonian gorillas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Structural proteins of the HIV virus

A

Gag- core of the vit ion
Pol- protease
Env- envelope glycoprotein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

HIV replication cycle

A

Gp120 binds with Cd4 in Th
Co factor CcR5 and CxCR4

Conformational change: fusion with host cell membrane via gp41

Uncoating of the capsid protein, facilitates reverse transcription and formation of pre integration complex (viral RNA, accessory proteins, capsid and matrix proteins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Risk for HIV transmission with unprotected receptive anal intercourse (URAI)

A

1.4%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Primary determinant of HuV 1 transmission

A

Quantity of HiV1 in the plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Transmission of the HIV virus is rare when how many copies RNA/ milliliter

A
33
Q

What is TasP (treatment as prevention)?

A

Initiation of antiretroviral therapy even before CD4 levels go below 250 is assoxiated with 96% reduction of HIV transmission

34
Q

HIV infection following skin puncture

A

0.3%

35
Q

HIav infection following mucous membrane exposure

A

0.09%

36
Q

Maternal transmission of HIV Occurs most commonly in the

A

Perinatal period

37
Q

Probability of transmission of HIV from mother to infant fetus

A

23-30% before birth
50-65% during birth 😄
12-20% breast feeding

38
Q

MC form of heart disease assoc with HIV Infection

A

CAD

39
Q

White frond like lesions along lateral borders of the tongue and adjacent buccal mucosa

A

Oral hairy leukoplakia

Florid replication of EBV

40
Q

Reactivation pulmonary in HIV

A

Coccidiosis immitis

41
Q

MAC prophylaxis

When and how?

A

CD 4

42
Q

Risk of TB Reactivation

HIV VS no HIV

A

HIV 7-10

No HIV 1%

43
Q

Causes ophthalmic lesion of choroid like buergers disease, bone marrow hypo plastic and otic involvement (polyploid mass in external auditory canal)

A

P jiroveci

44
Q

HIV opportunistic infections covered by TMP/SMX DS tablet BID

A

PCP

Toxoplasma

45
Q

Treatment for oral hairy leukoplakia

A

Podophyllin

46
Q

Hallmark of HIV assoc nephropathy

A

Proteinuria

Microalbuminuria found in 20% of AIDS

47
Q

MC presentation of syphilis in HIV

A

Condylomata lata

48
Q

Suphilis

Ulcers ting lesion of the skin due to necrotizing vasculitis

A

Lues maligna

49
Q

Effect of HIV on VDRL and anti TPa

A

False positive VDRL due to polyclonal B call activation

False negative FTA ABs due to immunodeficiency

50
Q

Percent of HIV patients with jarischh herxheimer reaction upon RX

A

One third

51
Q

HIV patients receiving thymidine analogues and protease inhibitors endocrine disorder

A

Lipodystrophy
Elev TC
Elev TF
Hyperinsulinemia and hyperglycemia

52
Q

Drug associated with FATAL HYPERSENSITIVITY on rechallenge

Associated with the HLA B27 haplotype

A

ABACAVIR

53
Q

Hema

Characteristic feature of zidovudine therapy

A

Elevated MCV

54
Q

Most prevalent derma disorder in patients with HIV

A

Folliculitis

Unique form: eosinophilia pustular folliculitis

55
Q

MC cause of meningitis in AIDS patients

A

Crytococcus

56
Q

Most severe form of HIV assoc neuro cognitive disorder (HAND)

A

HIV associated dementia

57
Q

Treatment of cryptococcal meningitis

A

Amphoteric in B

Or liposomal amphoteric in with flucytosine at least 2 weeks

58
Q

Reservoir for smoldering cryptococcal infection

A

Prostate gland

59
Q

MC cause of seizures in HIV patient

A
  1. Mass lesions (toxoplasma> lymphoma)
  2. HIV encephalopathy
  3. Cryptococcal meningitis
60
Q

MC manifestation of yoxoplasmosis

A

Fever
Headache
Focal neurological deficit

61
Q

Treatment of toxoplasmosis

A

Pyrimethamine+ sulfadiazine

With leucovirin for 4-6 weeks

62
Q

Indication for brain biopsy in patient with toxoplasmosis

A

Px who to failed to respond to therapy 2-4 weeks

63
Q

Likelihood that the patient has toxoplasmosis in the setting of negative serology

A
64
Q

Most common form of polyneuropathy in HIV

A

Distal symmetric

65
Q

Causes of myopathy in HIV

A

HIV itself
Zidovudine
Generalized wasting syndrome

66
Q

Histologic hallmark of zidovudine induced myopathy

A

Red ragged fibers

67
Q

MC abnormal finding ophtha in HIV

A

Cotton wool spots

68
Q

Most devastating ophtha complication of HIV infection

A

CMV retinitis

69
Q

Therapy for CMV retinitis

A

Oral valve cockpit
IV gancyclovir
Foe aren’t

70
Q

Can cause acute retinal necrosis or progressive outer retinal necrosis

A

HSV and varicella

71
Q

Define generalized wasting in AIDS

A

involuntary weight loss of >10% associated with intermittent or constant fever and chronic diarrhea or fatigue lasting >30 days in the absence of a defined cause other than HIV infection

72
Q

Neoplasticism conditions considered to be AIDS defining

A

Kaposi’s sarcoma
NonHodgkins lymphoma
Invasive cervical carcinoma

73
Q

Multi centric neoplasm consisting of multiple vascular nodules appearing in the skin, mucous membranes and viscera

A

Kaposi’s sarcoma

74
Q

First line therapy for advanced KS

A

Liposomal daunorubicin

75
Q

3 main categories of lymphoma seen in patients with HIV infection

A

Grade III or IV Immunoblastic lymphoma
Burkitt’s lymphoma
Primary CNS lymphoma

76
Q

Majority of the Immunoblastic lymphoma in HIV patients

A

Diffuse large B cell lymphomas

77
Q

Management of AIDS associated kaposi sarcoma

A

Radiation
Intraleaional vinblastin
Cryotherapy

78
Q

Lymphoma not commonly seen in the setting of an immunodeficiency other than HIV

A

Burkitts lymphoma

Small noncleaved cell lymphoma